Abiomed posts wider Q4 loss, guides fiscal ’09 revenues below the Street
Medical device company Abiomed, Inc. (Nasdaq:ABMD) reported a wider-than-expected loss for its fiscal fourth quarter of 2008 this morning. Revenues for the quarter also fell short of the Street’s view. Additionally, Abiomed issued revenue guidance for fiscal 2009 below the Street.
Shares slid 4.39%, or $0.61, to $13.30 out of the gate. For detailed price information and recent news stories about Abiomed, click ABMD.
